Clinical trial tracking
Track every peptide clinical trial that matters.
Phase, sponsor, indication, and primary completion — filterable, searchable, and linked to ClinicalTrials.gov for verification.
Last updated:Jul 15, 2026Source:ClinicalTrials.govVerified:Manually reviewed by PeptidePlanet research teamData provider:PeptidePlanet Research
NCT-linked records
Every trial page links back to ClinicalTrials.gov for the primary registry entry.
Sponsor & phase filters
Slice trials by Phase 1–4, sponsor, or indication in seconds.
Readout timing
Primary completion dates and expected data readouts feed the FDA catalyst calendar.
Newsletter
Get the weekly PeptidePlanet brief.
Free weekly digest of peptide biotech catalysts, trial readouts, and FDA calendar events.
No spam. Unsubscribe anytime.
Frequently asked questions
- Where does the trial data come from?
- All trial records are sourced from the U.S. National Library of Medicine's ClinicalTrials.gov registry. Each entry on PeptidePlanet links back to its NCT identifier for verification.
- How is 'peptide' trial defined here?
- We include trials whose primary intervention is a peptide therapeutic — including GLP-1 agonists, PDCs, peptide vaccines, and other peptide-based drug candidates in interventional studies.
- Can I filter by phase or sponsor?
- Yes. The clinical trials page supports filtering by phase, sponsor, indication, and status, plus full-text search across trial titles.
- How often is trial data refreshed?
- Trial statuses are reviewed weekly. Each trial page shows its last-updated date and the ClinicalTrials.gov revision on record.